INVOKAMET XR (Janssen Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the INVOKAMET XR drug offered from Janssen Pharmaceuticals, Inc.. This Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: canagliflozin and metformin hydrochloride
SUBSTANCE NAME: CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-09-20
END MARKETING DATE: 0000-00-00


INVOKAMET XR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINVOKAMET XR from Janssen Pharmaceuticals, Inc.
LABELER NAME: Janssen Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50; 500(mg/1; mg/1)
START MARKETING DATE: 2016-09-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-940_631fdfe9-0aae-4f28-a8bb-5d52ed3c25f2
PRODUCT NDC: 50458-940
APPLICATION NUMBER: NDA205879

Other CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Pharmaceuticals, Inc.INVOKAMET XR